whether angiotensin receptor blockers should be used to prevent renal problems in type 2 diabetes
July 2001
Experts are debating whether angiotensin receptor blockers should be used to prevent renal problems in type 2 diabetes.
ACE inhibitors are usually the drugs of choice to prevent diabetic nephropathy. Now there's growing evidence that angiotensin receptor blockers (ARBs) also slow the progression of renal disease.
So far Cozaar (losartan) and Avapro (irbesartan) are shown to help. The other ARBs probably give the same benefit.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote